Research.Patient.info

Erosive hand osteoarthritis (EHOA) research hub

1 indexed studies · 0 currently recruiting

authorisedTherapeutic exploratory (Phase II)
Denosumab or Zoledronic acid for erosive hand osteoarthritis (EHOA) in patients with osteoporosis a randomized controlled trial (ZODIAC trial)
This clinical trial compares two bone-strengthening medicines, denosumab and zoledronic acid, in adults with both osteoporosis and erosive hand osteoarthritis. Researchers want to see which medicine is better at protecting finger joints from bone damage, easing joint pain, and improving everyday hand movement over a 12-month period.
Italy